# Subjects With Advanced or Metastatic Solid Tumor Malignancies

> **NCT05474859** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Xenthera, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Metastatic Solid Tumor
- Advanced Solid Tumor

## Interventions

- **DRUG:** XT-0528

## Key facts

- **NCT ID:** NCT05474859
- **Lead sponsor:** Xenthera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2028-01
- **Final completion:** 2028-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05474859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05474859, "Subjects With Advanced or Metastatic Solid Tumor Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05474859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*